To include your compound in the COVID-19 Resource Center, submit it here.

Iovance raises $50M in follow-on

On Sept. 20, Iovance Biotherapeutics Inc. (NASDAQ:IOVA) raised $50

Read the full 92 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE